Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Michael Silverberg and Cynthia Campbell.
Connection Strength

3.737
  1. Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study. Lancet Child Adolesc Health. 2018 Oct; 2(10):707-714.
    View in: PubMed
    Score: 0.330
  2. Self-reported pain severity and use of cannabis and opioids in persons with HIV in an urban primary care setting in Northern California: A cross-sectional study. Medicine (Baltimore). 2024 Mar 29; 103(13):e37581.
    View in: PubMed
    Score: 0.244
  3. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst. 2013 Mar 06; 105(5):350-60.
    View in: PubMed
    Score: 0.224
  4. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis. 2012 Apr; 54(7):1026-34.
    View in: PubMed
    Score: 0.210
  5. Health care utilization and HIV clinical outcomes among newly enrolled patients following Affordable Care Act implementation in a California integrated health system: a longitudinal study. BMC Health Serv Res. 2020 Nov 11; 20(1):1030.
    View in: PubMed
    Score: 0.193
  6. Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women. Vaccine. 2020 06 15; 38(29):4520-4523.
    View in: PubMed
    Score: 0.186
  7. Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. J Gen Intern Med. 2009 Sep; 24(9):1065-72.
    View in: PubMed
    Score: 0.176
  8. Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy. J Pain Symptom Manage. 2009 Aug; 38(2):197-207.
    View in: PubMed
    Score: 0.172
  9. Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection. Ann Intern Med. 2009 Mar 03; 150(5):301-13.
    View in: PubMed
    Score: 0.171
  10. Do antiretrovirals reduce the risk of non-AIDS-defining malignancies? Curr Opin HIV AIDS. 2009 Jan; 4(1):42-51.
    View in: PubMed
    Score: 0.169
  11. Factors associated with hazardous alcohol use and motivation to reduce drinking among HIV primary care patients: Baseline findings from the Health & Motivation study. Addict Behav. 2018 Sep; 84:110-117.
    View in: PubMed
    Score: 0.161
  12. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era. Curr Opin Oncol. 2007 Sep; 19(5):446-51.
    View in: PubMed
    Score: 0.154
  13. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007 Apr 09; 167(7):684-91.
    View in: PubMed
    Score: 0.150
  14. Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics. J Acquir Immune Defic Syndr. 2016 Dec 15; 73(5):e76-e82.
    View in: PubMed
    Score: 0.147
  15. Effectiveness of highly-active antiretroviral therapy by race/ethnicity. AIDS. 2006 Jul 13; 20(11):1531-8.
    View in: PubMed
    Score: 0.143
  16. Demographic, Insurance, and Health Characteristics of Newly Enrolled HIV-Positive Patients After Implementation of the Affordable Care Act in California. Am J Public Health. 2016 07; 106(7):1211-3.
    View in: PubMed
    Score: 0.140
  17. Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. Clin Vaccine Immunol. 2006 Apr; 13(4):511-9.
    View in: PubMed
    Score: 0.140
  18. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis. 2004 Sep 01; 39(5):717-24.
    View in: PubMed
    Score: 0.125
  19. Prescription long-term opioid use in HIV-infected patients. Clin J Pain. 2012 Jan; 28(1):39-46.
    View in: PubMed
    Score: 0.104
  20. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2551-9.
    View in: PubMed
    Score: 0.103
  21. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health. 2010 Dec; 100(12):2541-7.
    View in: PubMed
    Score: 0.095
  22. HIV infection and the risk of cancers with and without a known infectious cause. AIDS. 2009 Nov 13; 23(17):2337-45.
    View in: PubMed
    Score: 0.090
  23. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010 Jan 19; 152(2):85-92.
    View in: PubMed
    Score: 0.023
  24. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009 Dec; 18(12):1166-75.
    View in: PubMed
    Score: 0.023
  25. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009 Nov-Dec; 31(6):564-70.
    View in: PubMed
    Score: 0.022
  26. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain. 2009 Oct; 145(3):287-93.
    View in: PubMed
    Score: 0.022
  27. De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008 Jul-Aug; 24(6):521-7.
    View in: PubMed
    Score: 0.020

© 2024 Kaiser Permanente